ACBP is an appetite stimulator across phylogenetic barriers
Authors:Frank Madeo1,2, Nektarios Tavernarakis3,4, José M. Bravo-San Pedro5-7,# and Guido Kroemer5-10,#
1 Institute of Molecular Biosciences, NAWI Graz, University of Graz, Humboldtstrasse 50, 8010 Graz, Austria.
2 BioTechMed Graz, Austria.
3 Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology-Hellas, Nikolaou Plastira 100, Heraklion 70013, Crete, Greece.
4 Department of Basic Sciences, Faculty of Medicine, University of Crete, Heraklion 71110, Crete, Greece.
5 Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France.
6 Inserm U1138, Centre de Recherche des Cordeliers, Sorbonne. Université, Université de Paris, 15 rue de l’école de médecine 75006, Paris, France.
7 Team “Metabolism, Cancer & Immunity”, équipe 11 labellisée par la Ligue contre le Cancer, Paris, France.
8 Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France.
9 Suzhou Institute for Systems Medicine, Chinese Academy of Sciences, Suzhou, China.
10 Karolinska Institute, Department of Women’s and Children’s Health, Karolinska University Hospital, Stockholm, Sweden.
# Share senior co-authorship.
Keywords:
anabolism, anorexia, appetite, catabolism, obesity.
Corresponding Author(s):
Conflict of interest statement:
JMBSP and GK filed a patent application dealing with tar-geting the ACBP/DBI system in anorexia, obesity and co-morbidities. GK filed additional patent applications dealing with caloric restriction mimetics (autophagy inducers) for the treatment of aging, age-related diseases, cancer, obesi-ty and comorbidities. GK is a scientific co-founder of Thera-fast Bio. MF and GK are scientific co-founders of Samsara Therapeutics.
Please cite this article as:
Frank Madeo, Nektarios Tavernarakis, José M. Bravo-San Pedro and Guido Kroemer (2020). ACBP is an appetite stimulator across phylogenetic barriers. Cell Stress 4(2): 27-29. doi: 10.15698/cst2020.02.211
© 2020 Madeo et al. This is an open-access article released under the terms of the Crea-tive Commons Attribution (CC BY) license, which allows the unrestricted use, distribution, and reproduction in any medium, provided the original author and source are acknowledged.